Massachusetts marijuana sales reached nearly $152 million in June—a record monthly high since the state’s adult-use market launched in November 2018—state data shows.
The Cannabis Control Commission (CCC) reported that recreational cannabis sales hit $132.8 last month, while medical marijuana purchases amounted to $19 million. The state has now seen $4.74 billion in adult-use sales since the market opened five years ago.
Flower products remained the most popular choice for adult consumers, followed by vape products, pre-rolls, edibles and concentrates. The average price of flower cannabis also dropped to a record low of $5.82 per gram last month, according to the CCC data.
The record sales are all the more notable given that adult-use markets are coming online and expanding in surrounding states like Connecticut and New York, too, which presumably would reduce purchases from out-of-state visitors. Connecticut also saw record high marijuana sales last month, at $24 million for the sixth months since the opening of the state’s recreational industry.
In another East Coast development, Maryland’s adult-use cannabis market launched this month. Marijuana sales topped $10 million during the opening weekend.
Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
In Massachusetts, data also showed for the first time last year that the state is generating more tax revenue from marijuana than alcohol.
“Marijuana Establishments and Medical Marijuana Treatment Centers offer tested products with detailed packaging and labeling information about product contents, statewide access for adults and patients seeking alternatives to the illicit market, and adult-use cannabis tax revenue for key initiatives including youth prevention campaigns and community reinvestment funds,” CCC said.
Meanwhile, it came to light this week that political strategists in Massachusetts have quietly filed paperwork to put a therapeutic psychedelics legalization initiative on the state’s 2024 ballot.
In the legislature, a Republican lawmaker recently filed three psychedelics reform bills, including proposals to legalize substances like psilocybin and reschedule MDMA pending federal approval while setting a price cap on therapeutic access.
There are several other pieces of psychedelics legislation that have been introduced in Massachusetts for the session by other legislators, including separate measures to legalize certain entheogenic substances for adults.
Another bill would authorize the Department of Public Health to conduct a comprehensive study into the potential therapeutic effects of synthetic psychedelics like MDMA.